Health
94% of patients with cancer respond well to Covid vax: Stud… – MENAFN.COM
New York, July 3 (IANS) Nearly 95 per cent of people with cancer developed a good immune response to the Covid-19 mRNA vaccines…
(MENAFN – IANS)
New York, July 3 (IANS) Nearly 95 per cent of people with cancer developed a good immune response to the Covid-19 mRNA vaccines three to four weeks after receiving their second dose, finds a new study co-authored by Indian-origin researchers.
…
Continue Reading
